Jay L. Goldstein

12.8k citations

158 papers · 9.3k indexed · 2 hit papers · h-index 43

Impact in

Gastroenterology top 0.1%
- Gastroesophageal reflux and treatments
- Gastrointestinal Bleeding Diagnosis and Treatment
Pharmacology top 0.05%
- Inflammatory mediators and NSAID effects
- Drug-Induced Adverse Reactions

Papers in

Gastroenterology 43
- Gastroesophageal reflux and treatments 31
Pharmacology 67
- Inflammatory mediators and NSAID effects 65
- Drug-Induced Adverse Reactions 14

Co-authors: Glenn M. Eisen Douglas O. Faigel Todd H. Baron J. Shawn Mallery Kenneth M. Verburg J. Patrick Waring William F. Stenson Fred E. Silverstein
Journals: Gastrointestinal Endoscopy (33 papers)Gastroenterology (27 papers)The American Journal of Gastroenterology (20 papers)Alimentary Pharmacology & Therapeutics (17 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (4 papers)
Partner nations: United States United Kingdom Spain

In The Last Decade

Jay L. Goldstein

153 papers receiving 8.8k citations

Hit Papers

align trajectories log scale

Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo 2005 · 482 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 Clinical Gastroenterology and Hepatology
2000 JAMA

Peers

Countries citing papers authored by Jay L. Goldstein

Since Specialization

Citations

This map shows the geographic impact of Jay L. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay L. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay L. Goldstein more than expected).

Fields of papers citing papers by Jay L. Goldstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay L. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay L. Goldstein. The network helps show where Jay L. Goldstein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jay L. Goldstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jay L. Goldstein Line = papers co-authored together Jay L. Goldstein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Localised chronic fibrosing vasculitis versus erythema elevatum diutinum BMJ Case Reports ·Suk Lan Flora Ko, William M. Lin, Jay L. Goldstein, 오경해, Steven T. Chen	2023	0
2	Screening Colonoscopy Withdrawal Time Threshold for Adequate Proximal Serrated Polyp Detection Rate Digestive Diseases and Sciences ·Hafzhi N. Azmi, William K. Thompson, Brittany Lapin, Jay L. Goldstein, Eugene F. Yen	2018	22
3	Long‐Term Safety of a Coordinated Delivery Tablet of Enteric‐Coated Aspirin 325 mg and Immediate‐Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk Cardiovascular Therapeutics ·Jay L. Goldstein, David J. Whellan, James M. Scheiman, Byron Cryer, Glenn M. Eisen, Ángel Lanas, John G. Fort	2016	7
4	Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial ( CONDOR ) Alimentary Pharmacology & Therapeutics ·Ángel Lanas, Jay L. Goldstein, Francis K.L. Chan, C. Mel Wilcox, David A. Peura, sedighe heydari nejad, Gina Sands, James M. Scheiman	2012	29
5	Does concomitant use of paracetamol potentiate the gastroduodenal mucosal injury associated with aspirin? A prospective, randomised, pilot study Alimentary Pharmacology & Therapeutics ·Justin Boike, Praopan Pratoomchat, Dan M. Meyer, M JKallok, 方国涛, Gemma Aiello (1), Adam C. Stein, Jamie Berkes, Jay L. Goldstein	2012	6
6	Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population‐based study Arthritis & Rheumatism ·Vera E. Valkhoff, Eva M. van Soest, Giampiero Mazzaglia, Mariam Molokhia, R Schade, Gianluca Trifirò, Jay L. Goldstein, Sonia Hernández–Dı́az, Ernst J. Kuipers, Miriam Sturkenboom	2012	13
7	GERD-Related Health Care Utilization, Therapy, and Reasons for Transfer of GERD Patients Between Primary Care Providers and Gastroenterologists in a US Managed Care Setting Digestive Diseases and Sciences ·Rachel Halpern, Smita Kothari, Mahesh Fuldeore, Victoria Zarotsky, Victoria Porter, Omar Dabbous, Jay L. Goldstein	2009	19
8	Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease‐related complications Alimentary Pharmacology & Therapeutics ·Douglas G. Manuel, A F Cutler, Jay L. Goldstein, M. Brian Fennerty, Kimberly Brown	2007	44
9	A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years Clinical Therapeutics ·Jay L. Goldstein, James Aisenberg, Frank L. Lanza, Howard Schwartz, George H. Sands, Manuela Berger, Sharon Pan	2006	18
10	Intragastric acid control in non‐steroidal anti‐inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole Alimentary Pharmacology & Therapeutics ·Jay L. Goldstein, Philip B. Miner, Paul K. Schlesinger, 杜祖亮, Debra G. Silberg	2006	21
11	Valdecoxib Is Associated with Improved Dyspepsia-Related Health Compared with Nonspecific NSAIDs in Patients with Osteoarthritis or Rheumatoid Arthritis The American Journal of Gastroenterology ·Linda Rabeneck, Jay L. Goldstein, A. T. Vu, Tracy J. Mayne, Dale Rublee	2005	10
12	Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo Clinical Gastroenterology and Hepatology ·Jay L. Goldstein, Glenn M. Eisen, Blair S. Lewis, Ian M. Gralnek, Steve Zlotnick, John G. Fort Hit paper breakdown →	2005	482
13	The role of endoscopy in the evaluation and treatment of patients with pancreaticobiliary malignancy Gastrointestinal Endoscopy ·Todd H. Baron, J. Shawn Mallery, William K. Hirota, Jay L. Goldstein, Brian C. Jacobson, Jonathan A. Leighton, J. Patrick Waring, Douglas O. Faigel	2003	57
14	Significant upper gastrointestinal events associated with conventional NSAID versus celecoxib. PubMed ·Jay L. Goldstein	2000	15
15	Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis JAMA ·Fred E. Silverstein, Gerald A. Faich, Jay L. Goldstein, Lee S. Simon, Theodore Pincus, Andrew Whelton, Robert Makuch, Glenn M. Eisen, N M Agrawal, William F. Stenson, Aimee Burr, Julia Winterlich, Jeffrey D. Kent, J B Lefkowith, Kenneth M. Verburg, Gilbert Geis Hit paper breakdown →	2000	2401
16	Reduced Risk of Upper Gastrointestinal Ulcer Complications With Celecoxib, A Novel Cox-2 Inhibitor The American Journal of Gastroenterology ·Jay L. Goldstein, Fred E. Silverstein, Naurang M. Agrawal, Richard C. Hubbard, Bilas Sylwia, Clement Maurath, Kenneth M. Verburg, Long Jian-bo	2000	232
17	Evidence for the presence of cGMP-dependent protein kinase-II in human distal colon and in T84, the colonic cell line Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Mohammad Sayim Wani, Abe E. Braverman, Jay L. Goldstein, Mrinalini C. Rao	2000	22
18	Who needs prophylaxis of nonsteroidal anti-inflammatory druginduced ulcers and what is optimal prophylaxis? European Journal of Gastroenterology & Hepatology ·Jay L. Goldstein	2000	9
19	Rabbit esophageal cells possess K+ channels: Effect of hyposmotic stress on channel activity Gastroenterology ·Jay L. Goldstein, 郭展維, Uri Filiba, Larry Schmidt, Antonius Schultingh, Thomas J. Layden	1993	10
20	In vivo evidence of altered chloride but not potassium secretion in cystic fibrosis rectal mucosa Gastroenterology ·Jay L. Goldstein, Scott Jordan Harris, Mrinalini C. Rao, Thomas J. Layden	1991	29

About Jay L. Goldstein

Jay L. Goldstein is a scholar working on Gastroenterology, Pharmacology, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 158 papers that have together received 9.3k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (65 papers), Helicobacter pylori-related gastroenterology studies (47 papers), Gastroesophageal reflux and treatments (31 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Esophageal and GI Pathology (15 papers), Eosinophilic Esophagitis (14 papers), Drug-Induced Adverse Reactions (14 papers) and Gastric Cancer Management and Outcomes (14 papers). The work is most often cited by research in Gastroenterology (2.0k citations), Pharmacology (3.8k citations), Anesthesiology and Pain Medicine (798 citations), Surgery (4.2k citations) and Biochemistry (498 citations). Jay L. Goldstein has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Glenn M. Eisen, Douglas O. Faigel, Todd H. Baron, J. Shawn Mallery, Kenneth M. Verburg, J. Patrick Waring, William F. Stenson, Fred E. Silverstein, Gilbert Geis and Aimee Burr. Their work appears in journals such as Gastrointestinal Endoscopy, Gastroenterology, The American Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics and American Journal of Physiology-Gastrointestinal and Liver Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact